Abstract
The sympathetic nervous system has been highlighted as an important therapeutic target for arterial hypertension (AH) by using renal denervation in patients and experimental models. Clinical studies in patients with chronic kidney disease (CKD) have shown that renal denervation, which destroys both sympathetic and sensory fibers that innervate the kidney, promotes not only renoprotective …